FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Chiesi USA, Inc. (New 03/20/2018)

Company Contact Information:
888-466-6505 x6511

Presentation Posting Date Related Information
Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10) 03/20/2018 The decision to discontinue the 0.2 mg/mL in 5% Dextrose formulation was business related and not related to product safety or efficacy. Other formulations of Cardene IV remain available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English